Boston Scientific Faces Class Action Lawsuit Over Alleged Misstatements and Market Growth Misrepresentation
Boston Scientific Corporation (BSX) is facing a class action lawsuit alleging that the company and its executives made false or misleading statements about its financial outlook and growth potential. Investors who purchased shares between July 23, 2025, and February 3, 2026, have until May 4, 2026, to seek lead plaintiff status in the lawsuit. The allegations include claims that Boston Scientific overstated its growth trajectory and failed to disclose risks from new competition.
Tickers: $BSX
Topics: Boston Scientific class action lawsuit SEC violations securities fraud